244 CMR 8.02
Initial Licensure as a Registered Nurse by Examination
(1) An applicant for initial licensure as a Registered Nurse by examination shall submit to the
Board the following documentation to establish the applicant's eligibility to write the NCLEX
RN:
(a) proof satisfactory to the Board of good moral character as required by M.G.L. c. 112,
§ 74 and as established by Board policy;
(b) proof satisfactory to the Board of the applicant's graduation from an approved nursing
1. if such program is located in the United States, the District of Columbia, or a U.S.
Territory, the applicant shall arrange for the following items to be sent directly to the
Board from the program:
a.
certification of graduation by the program administrator or the program
administrator's designee; and
b. an original transcript from the Registered Nurse education program from which
the applicant graduated verifying date of graduation and the credential conferred;
2. if such program is not located in the United States, the District of Columbia, a U.S.
Territory, or Canada, the applicant's graduate status shall be certified by the Board or its
designee bythe applicant's receipt of a CGFNS Certificate, a CGFNS credentials review,
or other Board-designated credentials review;
3. if such program is located in Canada and the applicant is not eligible for licensure by
reciprocity under 244 CMR 8.04(3), the applicant's graduate status shall be certified by
the Board or its designee;
(c) proof satisfactory to the Board that the applicant has achieved a minimum score as
specified by the Board on a Board-designated test of English proficiencywhere the applicant
(d) payment of all required fees, unless waived in accordance with M.G.L. c. 112, § 1B; and
(e)
after meeting the eligibility criteria in 244 CMR 8.02(1)(a) through (d), proof
satisfactory to the Board that the candidate has passed the NCLEX-RN during the NCLEX
eligibility period.
(2) A candidate who fails the NCLEX-RN may write the NCLEX-RN again as permitted by the
Board's NCLEX Retake Policy.